Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Aplastic Anemia

Blood & Immune

Aplastic Anemia Clinical Trials and Treatments

Also called bone marrow failure, pancytopenia, immune-mediated aplasia, Aplastic Anaemia

Aplastic anemia (AA) is a rare acquired or inherited bone marrow failure syndrome characterized by peripheral pancytopenia (anemia, thrombocytopenia, neutropenia) with hypocellular bone marrow and reduced hematopoietic precursors. Pathophysiology involves loss of hematopoietic stem cell and progenitor cell populations from multiple potential mechanisms: immune-mediated destruction (~50% of acquired cases via autoreactive T-cell cytotoxicity), direct toxic injury to stem cells (drug-induced from chemotherapy, antibiotics like chloramphenicol), viral infections (especially hepatitis-associated aplastic anemia), radiation exposure, chemical exposures (benzene), or genetic predisposition in inherited forms (Fanconi anemia, dyskeratosis congenita).

In plain words, aplastic anemia is a rare condition where the bone marrow inside the bones stops making enough new blood cells. Without enough blood cells, people can feel tired, bleed or bruise easily and catch infections more often.

Get an email when new Aplastic Anemia trials open or the FDA decides. Get alerts

Aplastic Anemia

Where treatments stand, from ClinicalTrials.gov and FDA labels

FDA review0

No decision pending. FDA calendar

FDA-approved medicines4

Alvaiz · ATGAM · Promacta · Omisirge

Aplastic Anemia has 4 FDA-approved medicines, 81 open or active clinical trials, and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Aplastic Anemia

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Aplastic Anemia

Aplastic anemia (AA) is a rare acquired or inherited bone marrow failure syndrome characterized by peripheral pancytopenia (anemia, thrombocytopenia, neutropenia) with hypocellular bone marrow and reduced hematopoietic precursors.

Keep reading about Aplastic Anemia

Pathophysiology involves loss of hematopoietic stem cell and progenitor cell populations from multiple potential mechanisms: immune-mediated destruction (~50% of acquired cases via autoreactive T-cell cytotoxicity), direct toxic injury to stem cells (drug-induced from chemotherapy, antibiotics like chloramphenicol), viral infections (especially hepatitis-associated aplastic anemia), radiation exposure, chemical exposures (benzene), or genetic predisposition in inherited forms (Fanconi anemia, dyskeratosis congenita).

The condition manifests with symptoms of anemia (fatigue, dyspnea, exercise intolerance), bleeding from thrombocytopenia (petechiae, mucosal bleeding, intracranial hemorrhage), and infections from neutropenia including fever and opportunistic infections. Diagnosis requires bone marrow examination showing hypocellularity (<25% cellularity) with reduced hematopoietic precursors. Severity is classified as non-severe, severe, or very severe based on neutrophil, platelet, and reticulocyte counts. Untreated severe aplastic anemia carries poor prognosis with high mortality from infections and hemorrhage.

What are the symptoms of Aplastic Anemia?

These are common symptoms of Aplastic Anemia, and how strong they are varies from person to person.

  • Fatigue and dyspnea from anemia
  • Petechiae and bleeding from thrombocytopenia
  • Infections from neutropenia
  • Fever without obvious source
  • Splenomegaly occasionally present
  • Macrocytic anemia on blood smear

Who gets Aplastic Anemia?

Can present at any age with bimodal distribution showing peaks at 20-25 years and 60+ years. Equal gender distribution overall. Can be idiopathic or secondary to drug exposures, radiation, or infections. Higher incidence in Asian populations compared to Western countries.

Increased risk with chemotherapy exposure, radiation therapy, immunosuppressive treatments, and certain infections. No clear ethnic predisposition for immune-mediated forms. Exposure history and temporal relationship to presumed trigger important for classification.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Aplastic Anemia?

There are currently 4 FDA-approved medications for Aplastic Anemia.

eltrombopag choline
Teva Pharmaceuticals
Search
antithymocyte globulin (horse)
Pfizer
Search
eltrombopag
Novartis (originally GlaxoSmithKline)
Search
Omisirge
omidubicel-onlv

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Aplastic Anemia treatment

Charity funds and drugmaker programs for Aplastic Anemia, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Every program and fund for Aplastic Anemia, by insurance →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Aplastic Anemia

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Aplastic Anemia resources

Reputable organizations and medical references for learning more about Aplastic Anemia, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Aplastic Anemia

Use this Aplastic Anemia clinical trial finder to see the 18 studies recruiting patients and 2 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 13 test a treatment and 7 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

81 active trials worldwide
Filter:
Sort:
Not yet recruitingObservational study, no treatment givenRecently updatedNCT07005297

Clinical Genetics Branch Eligibility Screening Survey

Sponsor: National Cancer Institute (NCI)

Background:

Ages 1 Year to 99 Years1 location
Expected to start Nov 2026Updated yesterdayEst. Jan 2035 (~8y 1m)
RecruitingTreatment trialRecently updatedNCT06689800

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

Intervention: Let's Get REAL

Sponsor: Washington University School of Medicine

The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pil...

Ages 8 Years+1 location
Started Nov 2024Updated yesterdayEst. Aug 2027 (~9 months)
RecruitingTreatment trialPhase 2Recently updatedNCT01174108

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Intervention: Miltenyi CD34 Reagent System, Donor derived G-CSF mobilized PBC

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Background:

Ages 4 Years to 80 Years1 location
Started Dec 2010Updated 6 days agoEst. Dec 2027 (~1y 1m)
RecruitingObservational study, no treatment givenRecently updatedNCT00027274

Cancer in Inherited Bone Marrow Failure Syndromes

Sponsor: National Cancer Institute (NCI)

Background:

A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.

Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers.

Ages 1 Day to 100 Years2 locations
Started Nov 2001Updated 6 days agoCompletion date not listed
RecruitingObservational study, no treatment givenRecently updatedNCT05687149

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia

Sponsor: National Cancer Institute (NCI)

Background:

Ages 8 Years to 90 Years1 location
Started Mar 2023Updated 1 week agoEst. Dec 2035 (~9y 1m)
Find Aplastic Anemia trials near you, ranked by distance →
Active trial locations96 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+88 more

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Early Phase 1
Phase 1
Phase 2
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Aplastic Anemia trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run an Aplastic Anemia foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Aplastic Anemia patient communities

Facebook groups, Reddit communities and YouTube channels where Aplastic Anemia patients, caregivers and advocacy groups talk.

Companies developing Aplastic Anemia treatments

Drugmakers that list Aplastic Anemia in their rare disease portfolio, 5 in all.

Questions people ask about Aplastic Anemia